{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:44:04Z","timestamp":1786160644735,"version":"build-2736575974"},"reference-count":16,"publisher":"Japan Endocrine Society","issue":"8","funder":[{"name":"National Hospital Organization","award":["R5-NHO(PI)-02"],"award-info":[{"award-number":["R5-NHO(PI)-02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0487","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:10:40Z","timestamp":1778537440000},"page":"983-991","source":"Crossref","is-referenced-by-count":0,"title":["Acanthosis nigricans as a diagnostic clue for familial partial lipodystrophy type 2: a case report with review of literature on Japanese cases"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1986-4808","authenticated-orcid":false,"given":"Takuya","family":"Kitamura","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, NHO Kyoto Medical Center, Kyoto, Japan"},{"name":"Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, NHO Kyoto Medical Center, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-3539","authenticated-orcid":false,"given":"Toru","family":"Kusakabe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, NHO Kyoto Medical Center, Kyoto, Japan"},{"name":"Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, NHO Kyoto Medical Center, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-3927","authenticated-orcid":false,"given":"Yuki","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, NHO Kyoto Medical Center, Kyoto, Japan"},{"name":"Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, NHO Kyoto Medical Center, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6266-3027","authenticated-orcid":false,"given":"Tetsuya","family":"Tagami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, NHO Kyoto Medical Center, Kyoto, Japan"},{"name":"Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, NHO Kyoto Medical Center, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-4196","authenticated-orcid":false,"given":"Kazuwa","family":"Nakao","sequence":"additional","affiliation":[{"name":"Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Tanaka T, Kusakabe T, Ebihara K, Aizawa-Abe M, Aotani D, et al. (2021) Practice guideline for lipodystrophy syndromes-clinically important diseases of the Japan Endocrine Society (JES). Endocr J 68: 1027\u20131042.","DOI":"10.1507\/endocrj.EJ21-0110"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Akinci B, von Schnurbein J, Araujo-Vilar D, Wabitsch M, Oral EA (2024) Lipodystrophy prevalence, \u201clipodystrophy-like phenotypes,\u201d and diagnostic challenges. Diabetes 73: 1039\u20131042.","DOI":"10.2337\/dbi24-0018"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3 Stone SI, Balasubramanyam A, Posey JE (2024) Atypical diabetes: what have we learned and what does the future hold? Diabetes Care 47: 770\u2013781.","DOI":"10.2337\/dci23-0038"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Akinci B, Oral EA, Neidert A, Rus D, Cheng WY, et al. (2019) Comorbidities and survival in patients with lipodystrophy: an international chart review study. J Clin Endocrinol Metab 104: 5120\u20135135.","DOI":"10.1210\/jc.2018-02730"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, et al. (2016) The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab 101: 4500\u20134511.","DOI":"10.1210\/jc.2016-2466"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Phiske MM (2014) An approach to acanthosis nigricans. Indian Dermatol Online J 5: 239\u2013249.","DOI":"10.4103\/2229-5178.137765"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Brown RJ, Akinci B, Yosef M, Phillips H, Khalatbari S, et al. (2025) Lipodystrophy severity score to assess disease burden in lipodystrophy. J Clin Endocrinol Metab 110: 3243\u20133255.","DOI":"10.1210\/clinem\/dgaf103"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Araki E, Tanaka A, Inagaki N, Ito H, Ueki K, et al. (2020) Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes\u2014a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society. Circ J 85: 82\u2013125.","DOI":"10.1253\/circj.CJ-20-0865"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Besci O, Foss de Freitas MC, Guidorizzi NR, Guler MC, Gilio D, et al. (2024) Deciphering the clinical presentations in LMNA-related lipodystrophy: report of 115 cases and a systematic review. J Clin Endocrinol Metab 109: e1204\u2013e1224.","DOI":"10.1210\/clinem\/dgad606"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 J\u00e9ru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O (2017) Clinical utility gene card for: familial partial lipodystrophy. Eur J Hum Genet 25: 2016.102.","DOI":"10.1038\/ejhg.2016.102"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Mosbah H, Vatier C, Andriss B, Belalem I, Delemer B, et al. (2024) Patients\u2019 perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy. Eur J Endocrinol 190: 23\u201333.","DOI":"10.1093\/ejendo\/lvad169"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kountouri A, Korakas E, Maratou E, Ikonomidis I, Balampanis K, et al. (2023) Familial partial lipodystrophy: clinical features, genetics and treatment in a Greek referral center. Int J Mol Sci 24: 12045.","DOI":"10.3390\/ijms241512045"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Brush M, Auh S, Cochran E, Tuska R, Koh C, et al. (2025) Effects of metreleptin in patients with generalized lipodystrophy before <i>vs.<\/i> after the onset of severe metabolic disease. J Clin Endocrinol Metab 110: e1051\u2013e1061.","DOI":"10.1210\/clinem\/dgae335"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Imachi H, Murao K, Ohtsuka S, Fujiwara M, Muraoka T, et al. (2009) A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A\/C (LMNA) mutations complicated by end-stage renal disease. Endocrine 35: 18\u201321.","DOI":"10.1007\/s12020-008-9127-1"},{"key":"15","unstructured":"15 Iogawa H, Ebihara K, Aotani D, Kusakabe T, Yamamoto S, et al. (2009) Leptin replacement therapy in partial lipodystrophy. Journal of Japan Society for the Study of Obesity 15: 195 (Abstract in Japanese)."},{"key":"16","unstructured":"16 Sako S, Shima K, Nagai K, Nakano Y, Takeshita Y, et al. (2025) A family with familial partial lipodystrophy (LMNA gene mutation) diagnosed due to hypertriglyceremia with hyperphagia. Folia Endocrinologica Japonica 101: 336 (Abstract in Japanese)."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/8\/73_EJ25-0487\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:28:55Z","timestamp":1786159735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/8\/73_EJ25-0487\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0487","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0487"}}